Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ICU MedicalSTU:IC7 80 Median PS Value is €236.18 as of Aug. 17, 2026, which is 100% below its 10-year median of 0.92. GuruFocus rates STU:IC7 with a GF Score™ of 80/100 and a GF Value™ of €105.79 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 336 Medical Devices & Instruments companies, ICU Medical ranks better than 54.76% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. ICU Medical's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was €74.142. ICU Medical's 10-Year median PS Ratio is 3.1855. Therefore, the Median PS Value for today is €236.18.
As of today (2026-08-17), ICU Medical's share price is €158.00. ICU Medical's Median PS Value is €236.18. Therefore, ICU Medical's Price to Median PS Value for today is 0.67.
The historical rank and industry rank for ICU Medical's Median PS Value or its related term are showing as below:
STU:IC7'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.29 Med: 0.92 Max: 2.39
Current: 0.67
During the past 13 years, the highest Price to Median PS Value of ICU Medical was 2.39. The lowest was 0.29. And the median was 0.92.
STU:IC7's Price-to-Median-PS-Value is ranked better than 54.76% of 336
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs STU:IC7: 0.67
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
ICU Medical's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
158.00
/
236.18
=
0.67
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical Median PS Value Related Terms
ICU Medical Median PS Value Historical Data
* Premium members only.
The historical data trend for ICU Medical's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:IC7 vs NVST, MMSI, MMED: Median PS Value Comparison
For the Medical Instruments & Supplies subindustry, ICU Medical's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where ICU Medical's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 3.1855.
ICU Medical's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €74.142.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (STU:IC7) has a Median PS Value of €236.18 as of Aug. 17, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on ICU Medical and its competitors. This is 25572% above median its historical median of 0.92. Over the past decade, ICU Medical's Median PS Value has ranged from 0.29 to 2.39. According to the industry distribution chart, ICU Medical ranks #152 out of 336 companies in the Medical Devices & Instruments industry, placing it in the top 45.2%.
Is ICU Medical's Median PS Value too high?
ICU Medical's current Median PS Value of €236.18 is 25572% above median its 10-year median of 0.92. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 2.39. Based on the distribution chart, ICU Medical ranks #152 out of 336 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, ICU Medical has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ICU Medical's Median PS Value compare to NVST and MMSI?
According to the Medical Devices & Instruments industry distribution chart, ICU Medical ranks #152 out of 336 companies for Median PS Value. This puts ICU Medical in the upper half of its industry. The industry median Median PS Value is 0.71. Historically, ICU Medical's own Median PS Value has ranged from 0.29 to 2.39 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on ICU Medical and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Medical's current Median PS Value is €236.18, which is 25572% above median its own 10-year median of 0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Medical stock overvalued right now?
Based on GuruFocus' analysis, ICU Medical (STU:IC7) is currently considered Significantly Overvalued. The stock's GF Value™ is €105.79, compared to a current price of €158.00 — trading 49.4% above its estimated fair value. The current Median PS Value is €236.18, which is 25572% above median its 10-year median of 0.92. ICU Medical's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For ICU Medical (STU:IC7), the current Median PS Value is €236.18 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICU Medical (STU:IC7) Overvalued in 2026?
Based on GuruFocus' analysis, ICU Medical stock appears to be overvalued.
The current stock price of €158.00 is trading 49.4% above its estimated GF Value™ of €105.79.
GuruFocus considers ICU Medical to be Significantly Overvalued.
Key valuation signals for STU:IC7:
Median PS Value: €236.18 (25572% above median its 10-year median of 0.92)
GF Value™: €105.79 vs. price of €158.00 (49.4% above fair value)
No single metric tells the full story. See the STU:IC7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
80GF Score
Get the complete analysis for STU:IC7
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:IC7 has been successfully added to your 
